THINK NOW, INC.
Mobile software teaching application for sustained attention control in ADHD using evidence-based experiential learning methods
- Sector
- Digital health
- Headquarters
- SAN FRANCISCO, CA
- Founded
- 2010
- Latest Form D
- $75K, Sep 2023
- Total capital
- $6.1M
- Federal grants
- $5.9M
- 11 awards · 2014–2022
- Sector median 0 awards
- Private capital raised
- $225K
- 2 Form D · last Sep 2023
- 37 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 2
- 3 pending · first 2022
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 2nd filing$75K
- Federal grantHealth and Human S · Phase II · Teaching attentional awareness and control in ADHD$45K
- Federal grantHealth and Human S · Phase II · Teaching attentional awareness and control in ADHD$848K
- Federal grantHealth and Human S · Phase II · Teaching attentional awareness and control in ADHD$1.1M
- Federal grantHealth and Human S · Phase II · Teaching attentional awareness and control in ADHD$1.1M
- Federal grantHealth and Human S · Phase II · Teaching attentional awareness and control in ADHD$523K
- Federal grantHealth and Human S · Phase II · Neurophysiological Attention Test (NAT) for Objective Assessment of ADHD$750K
- Private capital raisedForm D · SEC · 1st filing$150K
Show 5 earlier federal awards
- Federal grantHealth and Human S · Phase II · Neurophysiological Attention Test (NAT) for Objective Assessment of ADHD$749K
- Federal grantHealth and Human S · Phase II · Neurophysiological Attention Test (NAT) for Objective Assessment of ADHD$607K
- Federal grantHealth and Human S · Phase II · Neurophysiological Attention Test (NAT) for Objective Assessment of ADHD$51K
- Federal grantHealth and Human S · Phase I · Neurophysiological Attention Test (NAT)for Objective Assessment of ADHD$67K
- Federal grantHealth and Human S · Phase I · Training Attentional Awareness and Control in ADHD$80K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Founders and team
Researcher links verified by same-company patents and grants- Gregory V. SimpsonResearcherExecutive Officer, DirectorLinked by 2 patents · $5.9M in grants as PI
- Brett DeSchepperExecutive Officer, DirectorNamed in SEC Form D filings
- David E. CharronDirectorNamed in SEC Form D filings
- Michael M. MerzenichDirectorNamed in SEC Form D filings
What it has protected
USPTO · 2 granted of 5- PendingSystems And Methods For Assessing And Improving Sustained AttentionUSPTOApplication 18779000
- GrantedSystems And Methods For Assessing And Improving Sustained AttentionUSPTOUS 12,042,288
- PendingSystems And Methods For Mental Exercises And Improved CognitionUSPTOApplication 17842656
Show all 5 patent records
- Systems And Methods For Assessing And Improving Sustained AttentionJan 9, 2025 · Application 18779000Pending
- Systems And Methods For Assessing And Improving Sustained AttentionJul 23, 2024 · US 12,042,288Granted
- Systems And Methods For Mental Exercises And Improved CognitionDec 29, 2022 · Application 17842656Pending
- Systems And Methods For Assessing And Improving Sustained AttentionSep 27, 2022 · US 11,452,475Granted
- Systems And Methods For Mental Exercises And Improved CognitionApplication PCTUS2022034600Pending
Recent research by its founders
- Pupillary unrest is attenuated in attention deficit hyperactivity disorder (ADHD)20251 cites
- Training of Awareness in ADHD: Leveraging Metacognition20247 cites
- Pupillary dilations in a Target/Distractor visual task paradigm and attention deficit hyperactivity disorder (ADHD)20238 cites
Regulatory activity · Digital health
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .